Gordon Qian
Research Subjects
Research Interests
Gordon Qian has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Carolyn M. Sue
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network Chevy Chase Maryland USA
2 shared publications - Chenglong Yu
Monash University
2 shared publications - Christina Liang
Sydney Medical School, Faculty of Medicine and Health, Northern (Arabanoo) Precinct, University of Sydney, Camperdown, NSW, Australia
2 shared publications - Eloise Watson
Department of Neurogenetics, Kolling Institute, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia
2 shared publications - Joseph Copty
Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
2 shared publications - Joshua Wing Kei Ho
The University of Hong Kong
2 shared publications
Latest Publications
- Open Access
Mitochondrial Disease variation in healthy older adults: a genotype-phenotype assessment linking pathogenic variants and mitochondrial constraint
Mitochondrial diseases (MDs) are caused by variants in the mitochondrial (mtDNA) or nuclear (nDNA) genome and encompass a diverse disease spectrum, whilst mitochondrial dysfunction more broadly is implicated in aging and neurodegeneration, with distinct and overlapping phenotypic features. Recent population genomic studies reveal pathogenic MD variation to be common in the population and somatic mtDNA variants accumulate from the seventh decade. Cumulative burden of mtDNA variation, quantified using mitochondrial genome constraint measures, may mediate mitochondrial dysfunction generally. However, the clinical relevance of incidentally identified variation for MDs, and of mitochondrial constraint measures for aging and neurodegeneration, is unclear. We have quantified pathogenic mtDNA and nDNA variation, as well as measures of mitochondrial genome constraint in the Medical Genome Reference Bank (MGRB), a cohort of healthy older individuals. We evaluated association of identified pathogenic MD variants with clinical features relevant to MD across four domains including physical function, cognitive function, endocrine-metabolic function and mood. Associations of mitochondrial genome constraint with clinical measures of aging and neurodegeneration were also explored. No significant associations between MD variants and phenotypes were identified, although surprisingly, mood measures appeared healthier for variant carriers compared to non-carriers. Summed mtDNA constraint showed significant inverse association with blood pressure and a trend toward inverse association with physical function. Measures of cognitive function did not demonstrate association with summed or mean mitochondrial genome constraint. Pathogenic MD variants are relatively common in the population and may be carried through to old age in good health, emphasising the importance of clinical context for counselling. Mitochondrial genome constraint measures warrant further evaluation as a surrogate biomarker for mitochondrial genome quality and mitochondrial dysfunction.
Open AccessMitochondrial Disease variation in healthy older adults: a genotype-phenotype assessment linking pathogenic variants and mitochondrial constraint
Mitochondrial diseases (MDs) are caused by variants in the mitochondrial (mtDNA) or nuclear (nDNA) genome and encompass a diverse disease spectrum, whilst mitochondrial dysfunction more broadly is implicated in aging and neurodegeneration, with distinct and overlapping phenotypic features. Recent population genomic studies reveal pathogenic MD variation to be common in the population and somatic mtDNA variants accumulate from the seventh decade. Cumulative burden of mtDNA variation, quantified using mitochondrial genome constraint measures, may mediate mitochondrial dysfunction generally. However, the clinical relevance of incidentally identified variation for MDs, and of mitochondrial constraint measures for aging and neurodegeneration, is unclear. We have quantified pathogenic mtDNA and nDNA variation, as well as measures of mitochondrial genome constraint in the Medical Genome Reference Bank (MGRB), a cohort of healthy older individuals. We evaluated association of identified pathogenic MD variants with clinical features relevant to MD across four domains including physical function, cognitive function, endocrine-metabolic function and mood. Associations of mitochondrial genome constraint with clinical measures of aging and neurodegeneration were also explored. No significant associations between MD variants and phenotypes were identified, although surprisingly, mood measures appeared healthier for variant carriers compared to non-carriers. Summed mtDNA constraint showed significant inverse association with blood pressure and a trend toward inverse association with physical function. Measures of cognitive function did not demonstrate association with summed or mean mitochondrial genome constraint. Pathogenic MD variants are relatively common in the population and may be carried through to old age in good health, emphasising the importance of clinical context for counselling. Mitochondrial genome constraint measures warrant further evaluation as a surrogate biomarker for mitochondrial genome quality and mitochondrial dysfunction.
- Open Access
Pathogenic mitochondrial genome variation, heteroplasmy thresholding and mitochondrial constraint measures in a healthy older cohort
Mitochondrial diseases (MDs) are clinically heterogeneous rendering ascertainment challenging. Estimates of pathogenic mitochondrial DNA (mtDNA) variants in the population range from 1 in 200 to 1 in 4,000 individuals. Inclusion of mtDNA sequencing in genomic databases facilitates comprehensive estimation of mtDNA variation. However, interpretation of low heteroplasmy variation is complex, due in part to misalignment of nuclear mitochondrial DNA transcripts (NUMTs), whilst conservative heteroplasmy thresholds likely omit relevant variation. Cumulative burden of mtDNA variation contributes to aging and neurodegeneration, and recent characterisation of mitochondrial genome constraint allows quantitation of this burden. We analysed whole genome sequencing of blood DNA from 3,500 healthy older individuals in the Medical Genome Reference Bank using mity , considering pathogenic mtDNA variants ≥1% heteroplasmy. We identified 34 distinct pathogenic mtDNA variants in 62 individuals, giving a combined population allele frequency of 1.77% (95% CI 1.36-2.27) or 1 in 56 individuals. We evaluated inclusion of false positive (FP) calls due to two common NUMTs, which accounted for up to 16% of variants. Increasing heteroplasmy thresholding to eliminate all NUMT-FPs also eliminated much of the total variation, including pathogenic variants. We propose a sample-specific, scaled heteroplasmy threshold to maximise variant retention and mitigate NUMT-FPs. Finally, we characterised measures of mitochondrial constraint in this healthy older cohort, observing an association between variant burden and summed constraint, whilst mean constraint was higher in pathogenic variant carriers. These findings suggest pathogenic mtDNA variation is more common in the population than is currently appreciated. Findings are comparable to larger genomic databases when heteroplasmy thresholding is adjusted, and support earlier population-based estimates. Incorporation of low heteroplasmy variation is relevant, but interpretation is nuanced, and optimising variant retention requires consideration of NUMT-FP rates.
Open AccessPathogenic mitochondrial genome variation, heteroplasmy thresholding and mitochondrial constraint measures in a healthy older cohort
Mitochondrial diseases (MDs) are clinically heterogeneous rendering ascertainment challenging. Estimates of pathogenic mitochondrial DNA (mtDNA) variants in the population range from 1 in 200 to 1 in 4,000 individuals. Inclusion of mtDNA sequencing in genomic databases facilitates comprehensive estimation of mtDNA variation. However, interpretation of low heteroplasmy variation is complex, due in part to misalignment of nuclear mitochondrial DNA transcripts (NUMTs), whilst conservative heteroplasmy thresholds likely omit relevant variation. Cumulative burden of mtDNA variation contributes to aging and neurodegeneration, and recent characterisation of mitochondrial genome constraint allows quantitation of this burden. We analysed whole genome sequencing of blood DNA from 3,500 healthy older individuals in the Medical Genome Reference Bank using mity , considering pathogenic mtDNA variants ≥1% heteroplasmy. We identified 34 distinct pathogenic mtDNA variants in 62 individuals, giving a combined population allele frequency of 1.77% (95% CI 1.36-2.27) or 1 in 56 individuals. We evaluated inclusion of false positive (FP) calls due to two common NUMTs, which accounted for up to 16% of variants. Increasing heteroplasmy thresholding to eliminate all NUMT-FPs also eliminated much of the total variation, including pathogenic variants. We propose a sample-specific, scaled heteroplasmy threshold to maximise variant retention and mitigate NUMT-FPs. Finally, we characterised measures of mitochondrial constraint in this healthy older cohort, observing an association between variant burden and summed constraint, whilst mean constraint was higher in pathogenic variant carriers. These findings suggest pathogenic mtDNA variation is more common in the population than is currently appreciated. Findings are comparable to larger genomic databases when heteroplasmy thresholding is adjusted, and support earlier population-based estimates. Incorporation of low heteroplasmy variation is relevant, but interpretation is nuanced, and optimising variant retention requires consideration of NUMT-FP rates.
- Open Access
End-to-end evaluation of pipelines for metagenome-assembled genomes reveals hidden performance gaps
The generation of Metagenome Assembled Genomes (MAGs) has become a standard and basic step in the analysis of metagenomic data. This multi-step process, which includes assembly, binning, refinement, and quality control, has many alternative approaches, algorithms, and parameters. Determining the ideal approach for a given ecosystem and study, or highlighting algorithmic gaps in need of additional research and development, requires rigorous benchmarking. We present MAG-E ( MAG pipeline E valuator), a generalizable and expandable framework for end-to-end evaluation of entire MAG pipelines: from assembly, through binning, to quality control and filtering. MAG-E relies on simulations that are built to match an ecosystem of interest and provide a ground truth for accurate evaluation. To demonstrate the capabilities of MAG-E, we benchmark two assemblers, six binning algorithms, three binning modes, and three quality control and refinement methods in the context of the human gut microbiome. Our findings offer multiple insights into optimal MAG generation in this context. We find that metaSPAdes consistently outperforms MEGAHIT in terms of recall (completeness), and that COMEBin overall outperforms alternative binning algorithms, but has lower precision than SemiBin2. While multi-sample binning results in higher precision, as previously shown, single-sample binning has higher recall and leads to better overall performance with modern binners. Binning refinement, which combines bins from multiple different algorithms, leads to reduced performance. We further show that CheckM2 systematically overestimates completeness and underestimates contamination, and that this is partially ameliorated when using GUNC. Finally, we analyze performance at the contig level, and demonstrate that binning algorithms systematically underperform for prophages and fail to bin contigs that are shared between genomes. Overall, MAG-E offers deep insights into successes and gaps in this important analytic process.
Open AccessEnd-to-end evaluation of pipelines for metagenome-assembled genomes reveals hidden performance gaps
The generation of Metagenome Assembled Genomes (MAGs) has become a standard and basic step in the analysis of metagenomic data. This multi-step process, which includes assembly, binning, refinement, and quality control, has many alternative approaches, algorithms, and parameters. Determining the ideal approach for a given ecosystem and study, or highlighting algorithmic gaps in need of additional research and development, requires rigorous benchmarking. We present MAG-E ( MAG pipeline E valuator), a generalizable and expandable framework for end-to-end evaluation of entire MAG pipelines: from assembly, through binning, to quality control and filtering. MAG-E relies on simulations that are built to match an ecosystem of interest and provide a ground truth for accurate evaluation. To demonstrate the capabilities of MAG-E, we benchmark two assemblers, six binning algorithms, three binning modes, and three quality control and refinement methods in the context of the human gut microbiome. Our findings offer multiple insights into optimal MAG generation in this context. We find that metaSPAdes consistently outperforms MEGAHIT in terms of recall (completeness), and that COMEBin overall outperforms alternative binning algorithms, but has lower precision than SemiBin2. While multi-sample binning results in higher precision, as previously shown, single-sample binning has higher recall and leads to better overall performance with modern binners. Binning refinement, which combines bins from multiple different algorithms, leads to reduced performance. We further show that CheckM2 systematically overestimates completeness and underestimates contamination, and that this is partially ameliorated when using GUNC. Finally, we analyze performance at the contig level, and demonstrate that binning algorithms systematically underperform for prophages and fail to bin contigs that are shared between genomes. Overall, MAG-E offers deep insights into successes and gaps in this important analytic process.
- Open Access
Metagenomic coverage bias at transcription start sites is correlated with gene expression
Metagenomic sequencing is presumed to provide unbiased sampling of all the genetic material in a sample. Downstream analysis methods, such as binning, gene copy number analysis, structural variations, or single nucleotide polymorphism analysis, commonly assume an even distribution across the genome after accounting for known artefacts such as GC content. We discovered coverage bias across gut microbiome species, manifesting as a difference in coverage before and after bacterial transcription start sites. Using matched metatranscriptomic and metagenomic sequencing data, we demonstrate that this bias correlates with gene expression. Potential artefacts such as the sequencing technology, reference genome used for alignment, and mappability bias were investigated across multiple datasets and shown to not be factors for association. While GC bias was found correlated with coverage bias, the association of coverage bias with gene expression remains significant after adjusting for GC bias. Paired-end read mapping demonstrated an enrichment in 5’ read ends immediately downstream of the TSS which was partly a byproduct of unmapped reads upstream of the TSS. Our observations suggest the existence of strain-level variation where sequence variation in the promoter site region is preventing proper read alignment to the reference genome. The correlation of this phenomenon with gene expression may also reflect evolutionary footprints for fine-tuning the regulation of gene expression. Understanding the source of this sequence variation and the biological implications of this artefact will be useful not only to better characterise microbial functions but also to improve interpretations of strain level dynamics. Importance Sequencing coverage calculated from metagenomic sequencing data is extensively used in the microbiome field, providing valuable information about microbial abundances, gene (functional) abundances, growth rates, and genomic variations. Understanding factors that impact the distribution of coverage along genomes is therefore important for multiple applications. In this study, we report on uneven read coverage across the transcription start sites of bacterial genomes that is correlated with gene expression levels. We determine that this bias is independent of multiple factors including GC bias, and arises due to higher strain divergence from reference genomes upstream of the transcript start site. We propose that evolutionary finetuning of gene expression in competitive microbial ecosystems can drive genetic mutations at the promoter site. Our findings suggest the potential to glean gene regulatory information from metagenomic data, and better understand how ecological factors shape genomes in the microbiome and their sequencing coverage.
Open AccessMetagenomic coverage bias at transcription start sites is correlated with gene expression
Metagenomic sequencing is presumed to provide unbiased sampling of all the genetic material in a sample. Downstream analysis methods, such as binning, gene copy number analysis, structural variations, or single nucleotide polymorphism analysis, commonly assume an even distribution across the genome after accounting for known artefacts such as GC content. We discovered coverage bias across gut microbiome species, manifesting as a difference in coverage before and after bacterial transcription start sites. Using matched metatranscriptomic and metagenomic sequencing data, we demonstrate that this bias correlates with gene expression. Potential artefacts such as the sequencing technology, reference genome used for alignment, and mappability bias were investigated across multiple datasets and shown to not be factors for association. While GC bias was found correlated with coverage bias, the association of coverage bias with gene expression remains significant after adjusting for GC bias. Paired-end read mapping demonstrated an enrichment in 5’ read ends immediately downstream of the TSS which was partly a byproduct of unmapped reads upstream of the TSS. Our observations suggest the existence of strain-level variation where sequence variation in the promoter site region is preventing proper read alignment to the reference genome. The correlation of this phenomenon with gene expression may also reflect evolutionary footprints for fine-tuning the regulation of gene expression. Understanding the source of this sequence variation and the biological implications of this artefact will be useful not only to better characterise microbial functions but also to improve interpretations of strain level dynamics. Importance Sequencing coverage calculated from metagenomic sequencing data is extensively used in the microbiome field, providing valuable information about microbial abundances, gene (functional) abundances, growth rates, and genomic variations. Understanding factors that impact the distribution of coverage along genomes is therefore important for multiple applications. In this study, we report on uneven read coverage across the transcription start sites of bacterial genomes that is correlated with gene expression levels. We determine that this bias is independent of multiple factors including GC bias, and arises due to higher strain divergence from reference genomes upstream of the transcript start site. We propose that evolutionary finetuning of gene expression in competitive microbial ecosystems can drive genetic mutations at the promoter site. Our findings suggest the potential to glean gene regulatory information from metagenomic data, and better understand how ecological factors shape genomes in the microbiome and their sequencing coverage.
- Open Access
- 1 June 2023
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (6) , 1331-1342
Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
Background: Sex differences in the pathogenesis of hypertension exist. While gut microbiota (GM) has been associated with hypertension, it is unclear whether there are sex-linked differences in the association between GM and hypertension. Methods: We conducted a cross-sectional study to investigate the sex differences in associations between GM characterized by shotgun sequencing, GM-derived short-chain fatty acids, and 24-hour ambulatory blood pressure in 241 Hong Kong Chinese (113 men and 128 women; mean age, 54±6 years). Results: The hypertensive group was associated with GM alterations; however, significant differences in β-diversity and GM composition in hypertensive versus normotensive groups were only observed in women and not in men under various statistical models adjusting for the following covariates: age, sex, body mass index, sodium intake estimated by spot urine analysis, blood glucose, triglycerides, low- and high-density lipoprotein cholesterol, smoking, menopause, and fatty liver status. Specifically, Ruminococcus gnavus , Clostridium bolteae , and Bacteroides ovatus were significantly more abundant in the hypertensive women, whereas Dorea formicigenerans was more abundant in the normotensive women. No bacterial species were found to be significantly associated with hypertension in men. Furthermore, total plasma short-chain fatty acids and propionic acid were independent predictors of systolic and diastolic blood pressure in women but not men. Conclusions: GM dysregulation was strongly associated with 24-hour ambulatory blood pressure in women but not men, which may be mediated through propionic acid. Our work suggests that sex differences may be an important consideration while assessing the role of GM in the development and treatment of hypertension.
- 1 June 2023
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (6) , 1331-1342
Open AccessSex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
Background: Sex differences in the pathogenesis of hypertension exist. While gut microbiota (GM) has been associated with hypertension, it is unclear whether there are sex-linked differences in the association between GM and hypertension. Methods: We conducted a cross-sectional study to investigate the sex differences in associations between GM characterized by shotgun sequencing, GM-derived short-chain fatty acids, and 24-hour ambulatory blood pressure in 241 Hong Kong Chinese (113 men and 128 women; mean age, 54±6 years). Results: The hypertensive group was associated with GM alterations; however, significant differences in β-diversity and GM composition in hypertensive versus normotensive groups were only observed in women and not in men under various statistical models adjusting for the following covariates: age, sex, body mass index, sodium intake estimated by spot urine analysis, blood glucose, triglycerides, low- and high-density lipoprotein cholesterol, smoking, menopause, and fatty liver status. Specifically, Ruminococcus gnavus , Clostridium bolteae , and Bacteroides ovatus were significantly more abundant in the hypertensive women, whereas Dorea formicigenerans was more abundant in the normotensive women. No bacterial species were found to be significantly associated with hypertension in men. Furthermore, total plasma short-chain fatty acids and propionic acid were independent predictors of systolic and diastolic blood pressure in women but not men. Conclusions: GM dysregulation was strongly associated with 24-hour ambulatory blood pressure in women but not men, which may be mediated through propionic acid. Our work suggests that sex differences may be an important consideration while assessing the role of GM in the development and treatment of hypertension.